View Financial HealthLily Group 配当と自社株買い配当金 基準チェック /36Lily Group配当を支払う会社であり、現在の利回りは0.51%で、収益によって十分にカバーされています。主要情報0.5%配当利回り0.02%バイバック利回り総株主利回り0.5%将来の配当利回り0.5%配当成長5.7%次回配当支払日n/a配当落ち日n/a一株当たり配当金n/a配当性向33%最近の配当と自社株買いの更新Declared Dividend • Jun 02Dividend of CN¥0.15 announcedDividend of CN¥0.15 is the same as last year. Ex-date: 9th June 2025 Payment date: 9th June 2025 Dividend yield will be 1.5%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is well covered by both earnings (34% earnings payout ratio) and cash flows (20% cash payout ratio). The dividend has increased by an average of 10% per year over the past 8 years. However, payments have been volatile during that time. EPS is expected to grow by 26% over the next year, which should provide support to the dividend and adequate earnings cover.Upcoming Dividend • Jun 19Upcoming dividend of CN¥0.21 per share at 1.4% yieldEligible shareholders must have bought the stock before 26 June 2023. Payment date: 26 June 2023. Payout ratio is a comfortable 41% and the cash payout ratio is 91%. Trailing yield: 1.4%. Lower than top quartile of Chinese dividend payers (2.0%). Lower than average of industry peers (1.9%).すべての更新を表示Recent updatesValuation Update With 7 Day Price Move • May 14Investor sentiment improves as stock rises 18%After last week's 18% share price gain to CN¥20.94, the stock trades at a trailing P/E ratio of 53.1x. Average trailing P/E is 52x in the Chemicals industry in China. Total returns to shareholders of 89% over the past three years.Reported Earnings • Apr 23Full year 2025 earnings released: EPS: CN¥0.40 (vs CN¥0.43 in FY 2024)Full year 2025 results: EPS: CN¥0.40 (down from CN¥0.43 in FY 2024). Revenue: CN¥2.15b (down 11% from FY 2024). Net income: CN¥166.9m (down 5.2% from FY 2024). Profit margin: 7.8% (up from 7.3% in FY 2024). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 5% per year whereas the company’s share price has increased by 10% per year.お知らせ • Apr 23Lily Group Co., Ltd., Annual General Meeting, May 19, 2026Lily Group Co., Ltd., Annual General Meeting, May 19, 2026, at 14:00 China Standard Time. Location: 17F, No. 518, Pinglan Road, Xiaoshan District, Hangzhou, Zhejiang Chinaお知らせ • Mar 30Lily Group Co., Ltd. to Report Q1, 2026 Results on Apr 30, 2026Lily Group Co., Ltd. announced that they will report Q1, 2026 results on Apr 30, 2026New Risk • Mar 08New major risk - Revenue and earnings growthEarnings have declined by 15% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 15% per year over the past 5 years. Minor Risk Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past.Valuation Update With 7 Day Price Move • Jan 20Investor sentiment improves as stock rises 16%After last week's 16% share price gain to CN¥19.00, the stock trades at a forward P/E ratio of 29x. Average forward P/E is 28x in the Chemicals industry in China. Total returns to shareholders of 46% over the past three years.お知らせ • Dec 26Lily Group Co., Ltd. to Report Fiscal Year 2025 Results on Apr 23, 2026Lily Group Co., Ltd. announced that they will report fiscal year 2025 results on Apr 23, 2026Valuation Update With 7 Day Price Move • Nov 28Investor sentiment improves as stock rises 15%After last week's 15% share price gain to CN¥17.00, the stock trades at a forward P/E ratio of 26x. Average forward P/E is 23x in the Chemicals industry in China. Total returns to shareholders of 35% over the past three years.Valuation Update With 7 Day Price Move • Nov 04Investor sentiment improves as stock rises 27%After last week's 27% share price gain to CN¥19.39, the stock trades at a forward P/E ratio of 30x. Average forward P/E is 24x in the Chemicals industry in China. Total returns to shareholders of 55% over the past three years.New Risk • Nov 03New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 7.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (7.8% average weekly change).Reported Earnings • Oct 29Third quarter 2025 earnings released: EPS: CN¥0.082 (vs CN¥0.11 in 3Q 2024)Third quarter 2025 results: EPS: CN¥0.082 (down from CN¥0.11 in 3Q 2024). Revenue: CN¥512.4m (down 10% from 3Q 2024). Net income: CN¥35.9m (down 18% from 3Q 2024). Profit margin: 7.0% (down from 7.6% in 3Q 2024). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 23% p.a. on average during the next 2 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 6% per year but the company’s share price has increased by 10% per year, which means it is well ahead of earnings.Valuation Update With 7 Day Price Move • Sep 30Investor sentiment improves as stock rises 21%After last week's 21% share price gain to CN¥15.83, the stock trades at a forward P/E ratio of 26x. Average forward P/E is 23x in the Chemicals industry in China. Total returns to shareholders of 52% over the past three years.お知らせ • Sep 30Lily Group Co., Ltd. to Report Q3, 2025 Results on Oct 29, 2025Lily Group Co., Ltd. announced that they will report Q3, 2025 results on Oct 29, 2025New Risk • Sep 03New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Chinese stocks, typically moving 8.8% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (8.8% average weekly change). Minor Risk Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past.お知らせ • Jun 30Lily Group Co., Ltd. to Report First Half, 2025 Results on Aug 28, 2025Lily Group Co., Ltd. announced that they will report first half, 2025 results on Aug 28, 2025Valuation Update With 7 Day Price Move • Jun 24Investor sentiment improves as stock rises 19%After last week's 19% share price gain to CN¥13.54, the stock trades at a forward P/E ratio of 23x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 36% over the past three years.New Risk • Jun 24New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 8.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (8.2% average weekly change).Valuation Update With 7 Day Price Move • Jun 10Investor sentiment improves as stock rises 23%After last week's 23% share price gain to CN¥12.82, the stock trades at a forward P/E ratio of 22x. Average forward P/E is 21x in the Chemicals industry in China. Total returns to shareholders of 37% over the past three years.Declared Dividend • Jun 02Dividend of CN¥0.15 announcedDividend of CN¥0.15 is the same as last year. Ex-date: 9th June 2025 Payment date: 9th June 2025 Dividend yield will be 1.5%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is well covered by both earnings (34% earnings payout ratio) and cash flows (20% cash payout ratio). The dividend has increased by an average of 10% per year over the past 8 years. However, payments have been volatile during that time. EPS is expected to grow by 26% over the next year, which should provide support to the dividend and adequate earnings cover.Reported Earnings • Apr 27First quarter 2025 earnings released: EPS: CN¥0.11 (vs CN¥0.10 in 1Q 2024)First quarter 2025 results: EPS: CN¥0.11 (up from CN¥0.10 in 1Q 2024). Revenue: CN¥568.7m (down 3.6% from 1Q 2024). Net income: CN¥45.8m (up 13% from 1Q 2024). Profit margin: 8.1% (up from 6.9% in 1Q 2024). The increase in margin was driven by lower expenses. Revenue is forecast to grow 16% p.a. on average during the next 2 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 23% per year but the company’s share price has increased by 5% per year, which means it is well ahead of earnings.お知らせ • Apr 26Lily Group Co., Ltd., Annual General Meeting, May 19, 2025Lily Group Co., Ltd., Annual General Meeting, May 19, 2025, at 14:00 China Standard Time. Location: The Company's Meeting Room, Hangzhou, Zhejiang Chinaお知らせ • Mar 28Lily Group Co., Ltd. to Report Q1, 2025 Results on Apr 26, 2025Lily Group Co., Ltd. announced that they will report Q1, 2025 results on Apr 26, 2025Valuation Update With 7 Day Price Move • Mar 03Investor sentiment improves as stock rises 17%After last week's 17% share price gain to CN¥11.15, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 21x in the Chemicals industry in China. Total returns to shareholders of 5.5% over the past three years.分析記事 • Feb 27Many Still Looking Away From Lily Group Co., Ltd. (SHSE:603823)Lily Group Co., Ltd.'s ( SHSE:603823 ) price-to-earnings (or "P/E") ratio of 23.9x might make it look like a buy right...お知らせ • Dec 27Lily Group Co., Ltd. to Report Fiscal Year 2024 Results on Apr 26, 2025Lily Group Co., Ltd. announced that they will report fiscal year 2024 results on Apr 26, 2025Reported Earnings • Oct 28Third quarter 2024 earnings released: EPS: CN¥0.11 (vs CN¥0.07 in 3Q 2023)Third quarter 2024 results: EPS: CN¥0.11 (up from CN¥0.07 in 3Q 2023). Revenue: CN¥570.6m (down 3.9% from 3Q 2023). Net income: CN¥43.6m (up 65% from 3Q 2023). Profit margin: 7.6% (up from 4.5% in 3Q 2023). The increase in margin was driven by lower expenses. Revenue is forecast to grow 13% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 33% per year but the company’s share price has only fallen by 3% per year, which means it has not declined as severely as earnings.お知らせ • Sep 30Lily Group Co., Ltd. to Report Q3, 2024 Results on Oct 28, 2024Lily Group Co., Ltd. announced that they will report Q3, 2024 results on Oct 28, 2024Valuation Update With 7 Day Price Move • Sep 30Investor sentiment improves as stock rises 24%After last week's 24% share price gain to CN¥10.32, the stock trades at a forward P/E ratio of 18x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 11% over the past three years.分析記事 • Sep 28Market Still Lacking Some Conviction On Lily Group Co., Ltd. (SHSE:603823)When close to half the companies in China have price-to-earnings ratios (or "P/E's") above 29x, you may consider Lily...Reported Earnings • Aug 23Second quarter 2024 earnings released: EPS: CN¥0.14 (vs CN¥0.089 in 2Q 2023)Second quarter 2024 results: EPS: CN¥0.14 (up from CN¥0.089 in 2Q 2023). Revenue: CN¥631.1m (up 9.1% from 2Q 2023). Net income: CN¥59.6m (up 52% from 2Q 2023). Profit margin: 9.4% (up from 6.8% in 2Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 36% per year but the company’s share price has only fallen by 13% per year, which means it has not declined as severely as earnings.お知らせ • Jun 28Lily Group Co., Ltd. to Report First Half, 2024 Results on Aug 23, 2024Lily Group Co., Ltd. announced that they will report first half, 2024 results on Aug 23, 2024分析記事 • Jun 19More Unpleasant Surprises Could Be In Store For Lily Group Co., Ltd.'s (SHSE:603823) Shares After Tumbling 28%Lily Group Co., Ltd. ( SHSE:603823 ) shares have retraced a considerable 28% in the last month, reversing a fair amount...分析記事 • May 27Lily Group (SHSE:603823) Will Want To Turn Around Its Return TrendsIf you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...Valuation Update With 7 Day Price Move • May 24Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to CN¥11.75, the stock trades at a forward P/E ratio of 30x. Average forward P/E is 17x in the Chemicals industry in China. Total returns to shareholders of 3.7% over the past three years.Valuation Update With 7 Day Price Move • May 07Investor sentiment improves as stock rises 21%After last week's 21% share price gain to CN¥9.69, the stock trades at a forward P/E ratio of 25x. Average forward P/E is 18x in the Chemicals industry in China. Total loss to shareholders of 21% over the past three years.分析記事 • May 06Some Investors May Be Willing To Look Past Lily Group's (SHSE:603823) Soft EarningsSoft earnings didn't appear to concern Lily Group Co., Ltd.'s ( SHSE:603823 ) shareholders over the last week. Our...お知らせ • May 01Lily Group Co., Ltd., Annual General Meeting, May 20, 2024Lily Group Co., Ltd., Annual General Meeting, May 20, 2024, at 14:00 China Standard Time. Location: 17F, No. 520, Pinglan Road, Xiaoshan District, Hangzhou, Zhejiang ChinaReported Earnings • Apr 30Full year 2023 earnings: EPS in line with expectations, revenues disappointFull year 2023 results: EPS: CN¥0.29 (down from CN¥0.52 in FY 2022). Revenue: CN¥2.28b (down 7.5% from FY 2022). Net income: CN¥120.2m (down 44% from FY 2022). Profit margin: 5.3% (down from 8.7% in FY 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 5.2% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 30% per year but the company’s share price has only fallen by 15% per year, which means it has not declined as severely as earnings.分析記事 • Apr 07After Leaping 25% Lily Group Co., Ltd. (SHSE:603823) Shares Are Not Flying Under The RadarLily Group Co., Ltd. ( SHSE:603823 ) shareholders are no doubt pleased to see that the share price has bounced 25% in...Valuation Update With 7 Day Price Move • Apr 03Investor sentiment improves as stock rises 21%After last week's 21% share price gain to CN¥8.95, the stock trades at a forward P/E ratio of 26x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 28% over the past three years.お知らせ • Mar 30Lily Group Co., Ltd. to Report Q1, 2024 Results on Apr 30, 2024Lily Group Co., Ltd. announced that they will report Q1, 2024 results on Apr 30, 2024分析記事 • Feb 27Lily Group (SHSE:603823) Might Be Having Difficulty Using Its Capital EffectivelyTo find a multi-bagger stock, what are the underlying trends we should look for in a business? Amongst other things...Valuation Update With 7 Day Price Move • Feb 01Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to CN¥7.45, the stock trades at a forward P/E ratio of 21x. Average forward P/E is 13x in the Chemicals industry in China. Total loss to shareholders of 27% over the past three years.お知らせ • Dec 30Lily Group Co., Ltd. to Report Fiscal Year 2023 Results on Apr 30, 2024Lily Group Co., Ltd. announced that they will report fiscal year 2023 results on Apr 30, 2024Reported Earnings • Aug 31Second quarter 2023 earnings released: EPS: CN¥0.089 (vs CN¥0.20 in 2Q 2022)Second quarter 2023 results: EPS: CN¥0.089 (down from CN¥0.20 in 2Q 2022). Revenue: CN¥578.3m (down 22% from 2Q 2022). Net income: CN¥39.3m (down 52% from 2Q 2022). Profit margin: 6.8% (down from 11% in 2Q 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 10% per year whereas the company’s share price has fallen by 8% per year.Upcoming Dividend • Jun 19Upcoming dividend of CN¥0.21 per share at 1.4% yieldEligible shareholders must have bought the stock before 26 June 2023. Payment date: 26 June 2023. Payout ratio is a comfortable 41% and the cash payout ratio is 91%. Trailing yield: 1.4%. Lower than top quartile of Chinese dividend payers (2.0%). Lower than average of industry peers (1.9%).Reported Earnings • Apr 24Full year 2022 earnings: EPS and revenues miss analyst expectationsFull year 2022 results: EPS: CN¥0.67 (down from CN¥0.99 in FY 2021). Revenue: CN¥2.47b (flat on FY 2021). Net income: CN¥214.5m (down 31% from FY 2021). Profit margin: 8.7% (down from 13% in FY 2021). Revenue missed analyst estimates by 5.1%. Earnings per share (EPS) also missed analyst estimates by 15%. Revenue is forecast to grow 25% p.a. on average during the next 2 years, compared to a 17% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 7% per year but the company’s share price has fallen by 6% per year, which means it is significantly lagging earnings.Valuation Update With 7 Day Price Move • Nov 04Investor sentiment improved over the past weekAfter last week's 16% share price gain to CN¥16.42, the stock trades at a trailing P/E ratio of 17.2x. Average trailing P/E is 27x in the Chemicals industry in China. Total returns to shareholders of 6.5% over the past three years.Reported Earnings • Oct 28Third quarter 2022 earnings released: EPS: CN¥0.13 (vs CN¥0.20 in 3Q 2021)Third quarter 2022 results: EPS: CN¥0.13 (down from CN¥0.20 in 3Q 2021). Revenue: CN¥541.1m (down 7.6% from 3Q 2021). Net income: CN¥39.2m (down 39% from 3Q 2021). Profit margin: 7.2% (down from 11% in 3Q 2021). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings.Valuation Update With 7 Day Price Move • Oct 18Investor sentiment improved over the past weekAfter last week's 17% share price gain to CN¥16.16, the stock trades at a trailing P/E ratio of 16.9x. Average trailing P/E is 26x in the Chemicals industry in China. Total returns to shareholders of 1.2% over the past three years.Reported Earnings • Aug 26Second quarter 2022 earnings released: EPS: CN¥0.26 (vs CN¥0.26 in 2Q 2021)Second quarter 2022 results: EPS: CN¥0.26 (vs CN¥0.26 in 2Q 2021). Revenue: CN¥740.8m (up 16% from 2Q 2021). Net income: CN¥82.1m (flat on 2Q 2021). Profit margin: 11% (down from 13% in 2Q 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 15% per year but the company’s share price has only increased by 4% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Aug 01Investor sentiment improved over the past weekAfter last week's 18% share price gain to CN¥15.41, the stock trades at a trailing P/E ratio of 16.1x. Average trailing P/E is 29x in the Chemicals industry in China. Total returns to shareholders of 8.6% over the past three years.Reported Earnings • Apr 29First quarter 2022 earnings released: EPS: CN¥0.21 (vs CN¥0.24 in 1Q 2021)First quarter 2022 results: EPS: CN¥0.21 (down from CN¥0.24 in 1Q 2021). Revenue: CN¥646.3m (up 8.4% from 1Q 2021). Net income: CN¥66.8m (down 11% from 1Q 2021). Profit margin: 10% (down from 13% in 1Q 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has fallen by 9% per year, which means it is significantly lagging earnings.Reported Earnings • Nov 01Third quarter 2021 earnings released: EPS CN¥0.20 (vs CN¥0.23 in 3Q 2020)The company reported a soft third quarter result with weaker earnings and profit margins, although revenues improved. Third quarter 2021 results: Revenue: CN¥585.9m (up 14% from 3Q 2020). Net income: CN¥64.4m (down 13% from 3Q 2020). Profit margin: 11% (down from 14% in 3Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has only increased by 12% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Sep 29Investor sentiment deteriorated over the past weekAfter last week's 18% share price decline to CN¥15.44, the stock trades at a trailing P/E ratio of 15.6x. Average trailing P/E is 31x in the Chemicals industry in China. Total returns to shareholders of 49% over the past three years.Reported Earnings • Aug 26Second quarter 2021 earnings released: EPS CN¥0.26 (vs CN¥0.23 in 2Q 2020)The company reported a solid second quarter result with improved earnings and revenues, although profit margins were weaker. Second quarter 2021 results: Revenue: CN¥641.3m (up 24% from 2Q 2020). Net income: CN¥82.4m (up 15% from 2Q 2020). Profit margin: 13% (down from 14% in 2Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 18% per year whereas the company’s share price has increased by 17% per year.Reported Earnings • Apr 17Full year 2020 earnings released: EPS CN¥0.82 (vs CN¥0.72 in FY 2019)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: CN¥2.01b (up 1.2% from FY 2019). Net income: CN¥259.6m (up 14% from FY 2019). Profit margin: 13% (up from 12% in FY 2019). Over the last 3 years on average, earnings per share has increased by 17% per year whereas the company’s share price has increased by 16% per year.Is New 90 Day High Low • Jan 27New 90-day low: CN¥13.86The company is down 5.0% from its price of CN¥14.62 on 29 October 2020. The Chinese market is up 9.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 21% over the same period.Is New 90 Day High Low • Dec 16New 90-day low: CN¥13.90The company is down 10.0% from its price of CN¥15.52 on 17 September 2020. The Chinese market is up 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 6.0% over the same period.Is New 90 Day High Low • Oct 30New 90-day low: CN¥14.15The company is down 19% from its price of CN¥17.37 on 31 July 2020. The Chinese market is down 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 2.0% over the same period.Reported Earnings • Oct 28Third quarter earnings releasedOver the last 12 months the company has reported total profits of CN¥229.5m, up 7.6% from the prior year. Total revenue was CN¥1.91b over the last 12 months, down 1.5% from the prior year.Is New 90 Day High Low • Sep 24New 90-day low: CN¥14.88The company is down 15% from its price of CN¥17.51 on 24 June 2020. The Chinese market is up 12% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 21% over the same period.決済の安定と成長配当データの取得安定した配当: 603823は 10 年未満配当金を支払っており、この間、支払額は 変動性 が高かった。増加する配当: 603823の配当金は増加していますが、同社は9年間しか配当金を支払っていません。配当利回り対市場Lily Group 配当利回り対市場603823 配当利回りは市場と比べてどうか？セグメント配当利回り会社 (603823)0.5%市場下位25% (CN)0.4%市場トップ25% (CN)2.0%業界平均 (Chemicals)1.3%アナリスト予想 (603823) (最長3年)0.5%注目すべき配当: 603823の配当金 ( 0.51% ) はCN市場の配当金支払者の下位 25% ( 0.37% ) よりも高くなっています。高配当: 603823の配当金 ( 0.51% ) はCN市場の配当金支払者の上位 25% ( 2.01% ) と比較すると低いです。株主への利益配当収益カバレッジ: 603823の 配当性向 ( 33.3% ) はかなり低いため、配当金の支払いは利益によって十分にカバーされます。株主配当金キャッシュフローカバレッジ: 603823の 現金配当性向 ( 30.2% ) は比較的低く、配当金の支払いはキャッシュフローによって十分にカバーされています。高配当企業の発掘7D1Y7D1Y7D1YCN 市場の強力な配当支払い企業。View Management企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/29 23:03終値2026/05/29 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Lily Group Co., Ltd. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。2 アナリスト機関Nai Di ZhaoEverbright Securities Co. Ltd.Wenxi JinTopsperity Securities
Declared Dividend • Jun 02Dividend of CN¥0.15 announcedDividend of CN¥0.15 is the same as last year. Ex-date: 9th June 2025 Payment date: 9th June 2025 Dividend yield will be 1.5%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is well covered by both earnings (34% earnings payout ratio) and cash flows (20% cash payout ratio). The dividend has increased by an average of 10% per year over the past 8 years. However, payments have been volatile during that time. EPS is expected to grow by 26% over the next year, which should provide support to the dividend and adequate earnings cover.
Upcoming Dividend • Jun 19Upcoming dividend of CN¥0.21 per share at 1.4% yieldEligible shareholders must have bought the stock before 26 June 2023. Payment date: 26 June 2023. Payout ratio is a comfortable 41% and the cash payout ratio is 91%. Trailing yield: 1.4%. Lower than top quartile of Chinese dividend payers (2.0%). Lower than average of industry peers (1.9%).
Valuation Update With 7 Day Price Move • May 14Investor sentiment improves as stock rises 18%After last week's 18% share price gain to CN¥20.94, the stock trades at a trailing P/E ratio of 53.1x. Average trailing P/E is 52x in the Chemicals industry in China. Total returns to shareholders of 89% over the past three years.
Reported Earnings • Apr 23Full year 2025 earnings released: EPS: CN¥0.40 (vs CN¥0.43 in FY 2024)Full year 2025 results: EPS: CN¥0.40 (down from CN¥0.43 in FY 2024). Revenue: CN¥2.15b (down 11% from FY 2024). Net income: CN¥166.9m (down 5.2% from FY 2024). Profit margin: 7.8% (up from 7.3% in FY 2024). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 5% per year whereas the company’s share price has increased by 10% per year.
お知らせ • Apr 23Lily Group Co., Ltd., Annual General Meeting, May 19, 2026Lily Group Co., Ltd., Annual General Meeting, May 19, 2026, at 14:00 China Standard Time. Location: 17F, No. 518, Pinglan Road, Xiaoshan District, Hangzhou, Zhejiang China
お知らせ • Mar 30Lily Group Co., Ltd. to Report Q1, 2026 Results on Apr 30, 2026Lily Group Co., Ltd. announced that they will report Q1, 2026 results on Apr 30, 2026
New Risk • Mar 08New major risk - Revenue and earnings growthEarnings have declined by 15% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 15% per year over the past 5 years. Minor Risk Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past.
Valuation Update With 7 Day Price Move • Jan 20Investor sentiment improves as stock rises 16%After last week's 16% share price gain to CN¥19.00, the stock trades at a forward P/E ratio of 29x. Average forward P/E is 28x in the Chemicals industry in China. Total returns to shareholders of 46% over the past three years.
お知らせ • Dec 26Lily Group Co., Ltd. to Report Fiscal Year 2025 Results on Apr 23, 2026Lily Group Co., Ltd. announced that they will report fiscal year 2025 results on Apr 23, 2026
Valuation Update With 7 Day Price Move • Nov 28Investor sentiment improves as stock rises 15%After last week's 15% share price gain to CN¥17.00, the stock trades at a forward P/E ratio of 26x. Average forward P/E is 23x in the Chemicals industry in China. Total returns to shareholders of 35% over the past three years.
Valuation Update With 7 Day Price Move • Nov 04Investor sentiment improves as stock rises 27%After last week's 27% share price gain to CN¥19.39, the stock trades at a forward P/E ratio of 30x. Average forward P/E is 24x in the Chemicals industry in China. Total returns to shareholders of 55% over the past three years.
New Risk • Nov 03New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 7.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (7.8% average weekly change).
Reported Earnings • Oct 29Third quarter 2025 earnings released: EPS: CN¥0.082 (vs CN¥0.11 in 3Q 2024)Third quarter 2025 results: EPS: CN¥0.082 (down from CN¥0.11 in 3Q 2024). Revenue: CN¥512.4m (down 10% from 3Q 2024). Net income: CN¥35.9m (down 18% from 3Q 2024). Profit margin: 7.0% (down from 7.6% in 3Q 2024). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 23% p.a. on average during the next 2 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 6% per year but the company’s share price has increased by 10% per year, which means it is well ahead of earnings.
Valuation Update With 7 Day Price Move • Sep 30Investor sentiment improves as stock rises 21%After last week's 21% share price gain to CN¥15.83, the stock trades at a forward P/E ratio of 26x. Average forward P/E is 23x in the Chemicals industry in China. Total returns to shareholders of 52% over the past three years.
お知らせ • Sep 30Lily Group Co., Ltd. to Report Q3, 2025 Results on Oct 29, 2025Lily Group Co., Ltd. announced that they will report Q3, 2025 results on Oct 29, 2025
New Risk • Sep 03New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Chinese stocks, typically moving 8.8% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (8.8% average weekly change). Minor Risk Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past.
お知らせ • Jun 30Lily Group Co., Ltd. to Report First Half, 2025 Results on Aug 28, 2025Lily Group Co., Ltd. announced that they will report first half, 2025 results on Aug 28, 2025
Valuation Update With 7 Day Price Move • Jun 24Investor sentiment improves as stock rises 19%After last week's 19% share price gain to CN¥13.54, the stock trades at a forward P/E ratio of 23x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 36% over the past three years.
New Risk • Jun 24New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 8.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (8.2% average weekly change).
Valuation Update With 7 Day Price Move • Jun 10Investor sentiment improves as stock rises 23%After last week's 23% share price gain to CN¥12.82, the stock trades at a forward P/E ratio of 22x. Average forward P/E is 21x in the Chemicals industry in China. Total returns to shareholders of 37% over the past three years.
Declared Dividend • Jun 02Dividend of CN¥0.15 announcedDividend of CN¥0.15 is the same as last year. Ex-date: 9th June 2025 Payment date: 9th June 2025 Dividend yield will be 1.5%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is well covered by both earnings (34% earnings payout ratio) and cash flows (20% cash payout ratio). The dividend has increased by an average of 10% per year over the past 8 years. However, payments have been volatile during that time. EPS is expected to grow by 26% over the next year, which should provide support to the dividend and adequate earnings cover.
Reported Earnings • Apr 27First quarter 2025 earnings released: EPS: CN¥0.11 (vs CN¥0.10 in 1Q 2024)First quarter 2025 results: EPS: CN¥0.11 (up from CN¥0.10 in 1Q 2024). Revenue: CN¥568.7m (down 3.6% from 1Q 2024). Net income: CN¥45.8m (up 13% from 1Q 2024). Profit margin: 8.1% (up from 6.9% in 1Q 2024). The increase in margin was driven by lower expenses. Revenue is forecast to grow 16% p.a. on average during the next 2 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 23% per year but the company’s share price has increased by 5% per year, which means it is well ahead of earnings.
お知らせ • Apr 26Lily Group Co., Ltd., Annual General Meeting, May 19, 2025Lily Group Co., Ltd., Annual General Meeting, May 19, 2025, at 14:00 China Standard Time. Location: The Company's Meeting Room, Hangzhou, Zhejiang China
お知らせ • Mar 28Lily Group Co., Ltd. to Report Q1, 2025 Results on Apr 26, 2025Lily Group Co., Ltd. announced that they will report Q1, 2025 results on Apr 26, 2025
Valuation Update With 7 Day Price Move • Mar 03Investor sentiment improves as stock rises 17%After last week's 17% share price gain to CN¥11.15, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 21x in the Chemicals industry in China. Total returns to shareholders of 5.5% over the past three years.
分析記事 • Feb 27Many Still Looking Away From Lily Group Co., Ltd. (SHSE:603823)Lily Group Co., Ltd.'s ( SHSE:603823 ) price-to-earnings (or "P/E") ratio of 23.9x might make it look like a buy right...
お知らせ • Dec 27Lily Group Co., Ltd. to Report Fiscal Year 2024 Results on Apr 26, 2025Lily Group Co., Ltd. announced that they will report fiscal year 2024 results on Apr 26, 2025
Reported Earnings • Oct 28Third quarter 2024 earnings released: EPS: CN¥0.11 (vs CN¥0.07 in 3Q 2023)Third quarter 2024 results: EPS: CN¥0.11 (up from CN¥0.07 in 3Q 2023). Revenue: CN¥570.6m (down 3.9% from 3Q 2023). Net income: CN¥43.6m (up 65% from 3Q 2023). Profit margin: 7.6% (up from 4.5% in 3Q 2023). The increase in margin was driven by lower expenses. Revenue is forecast to grow 13% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 33% per year but the company’s share price has only fallen by 3% per year, which means it has not declined as severely as earnings.
お知らせ • Sep 30Lily Group Co., Ltd. to Report Q3, 2024 Results on Oct 28, 2024Lily Group Co., Ltd. announced that they will report Q3, 2024 results on Oct 28, 2024
Valuation Update With 7 Day Price Move • Sep 30Investor sentiment improves as stock rises 24%After last week's 24% share price gain to CN¥10.32, the stock trades at a forward P/E ratio of 18x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 11% over the past three years.
分析記事 • Sep 28Market Still Lacking Some Conviction On Lily Group Co., Ltd. (SHSE:603823)When close to half the companies in China have price-to-earnings ratios (or "P/E's") above 29x, you may consider Lily...
Reported Earnings • Aug 23Second quarter 2024 earnings released: EPS: CN¥0.14 (vs CN¥0.089 in 2Q 2023)Second quarter 2024 results: EPS: CN¥0.14 (up from CN¥0.089 in 2Q 2023). Revenue: CN¥631.1m (up 9.1% from 2Q 2023). Net income: CN¥59.6m (up 52% from 2Q 2023). Profit margin: 9.4% (up from 6.8% in 2Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 36% per year but the company’s share price has only fallen by 13% per year, which means it has not declined as severely as earnings.
お知らせ • Jun 28Lily Group Co., Ltd. to Report First Half, 2024 Results on Aug 23, 2024Lily Group Co., Ltd. announced that they will report first half, 2024 results on Aug 23, 2024
分析記事 • Jun 19More Unpleasant Surprises Could Be In Store For Lily Group Co., Ltd.'s (SHSE:603823) Shares After Tumbling 28%Lily Group Co., Ltd. ( SHSE:603823 ) shares have retraced a considerable 28% in the last month, reversing a fair amount...
分析記事 • May 27Lily Group (SHSE:603823) Will Want To Turn Around Its Return TrendsIf you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...
Valuation Update With 7 Day Price Move • May 24Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to CN¥11.75, the stock trades at a forward P/E ratio of 30x. Average forward P/E is 17x in the Chemicals industry in China. Total returns to shareholders of 3.7% over the past three years.
Valuation Update With 7 Day Price Move • May 07Investor sentiment improves as stock rises 21%After last week's 21% share price gain to CN¥9.69, the stock trades at a forward P/E ratio of 25x. Average forward P/E is 18x in the Chemicals industry in China. Total loss to shareholders of 21% over the past three years.
分析記事 • May 06Some Investors May Be Willing To Look Past Lily Group's (SHSE:603823) Soft EarningsSoft earnings didn't appear to concern Lily Group Co., Ltd.'s ( SHSE:603823 ) shareholders over the last week. Our...
お知らせ • May 01Lily Group Co., Ltd., Annual General Meeting, May 20, 2024Lily Group Co., Ltd., Annual General Meeting, May 20, 2024, at 14:00 China Standard Time. Location: 17F, No. 520, Pinglan Road, Xiaoshan District, Hangzhou, Zhejiang China
Reported Earnings • Apr 30Full year 2023 earnings: EPS in line with expectations, revenues disappointFull year 2023 results: EPS: CN¥0.29 (down from CN¥0.52 in FY 2022). Revenue: CN¥2.28b (down 7.5% from FY 2022). Net income: CN¥120.2m (down 44% from FY 2022). Profit margin: 5.3% (down from 8.7% in FY 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 5.2% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 30% per year but the company’s share price has only fallen by 15% per year, which means it has not declined as severely as earnings.
分析記事 • Apr 07After Leaping 25% Lily Group Co., Ltd. (SHSE:603823) Shares Are Not Flying Under The RadarLily Group Co., Ltd. ( SHSE:603823 ) shareholders are no doubt pleased to see that the share price has bounced 25% in...
Valuation Update With 7 Day Price Move • Apr 03Investor sentiment improves as stock rises 21%After last week's 21% share price gain to CN¥8.95, the stock trades at a forward P/E ratio of 26x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 28% over the past three years.
お知らせ • Mar 30Lily Group Co., Ltd. to Report Q1, 2024 Results on Apr 30, 2024Lily Group Co., Ltd. announced that they will report Q1, 2024 results on Apr 30, 2024
分析記事 • Feb 27Lily Group (SHSE:603823) Might Be Having Difficulty Using Its Capital EffectivelyTo find a multi-bagger stock, what are the underlying trends we should look for in a business? Amongst other things...
Valuation Update With 7 Day Price Move • Feb 01Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to CN¥7.45, the stock trades at a forward P/E ratio of 21x. Average forward P/E is 13x in the Chemicals industry in China. Total loss to shareholders of 27% over the past three years.
お知らせ • Dec 30Lily Group Co., Ltd. to Report Fiscal Year 2023 Results on Apr 30, 2024Lily Group Co., Ltd. announced that they will report fiscal year 2023 results on Apr 30, 2024
Reported Earnings • Aug 31Second quarter 2023 earnings released: EPS: CN¥0.089 (vs CN¥0.20 in 2Q 2022)Second quarter 2023 results: EPS: CN¥0.089 (down from CN¥0.20 in 2Q 2022). Revenue: CN¥578.3m (down 22% from 2Q 2022). Net income: CN¥39.3m (down 52% from 2Q 2022). Profit margin: 6.8% (down from 11% in 2Q 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 10% per year whereas the company’s share price has fallen by 8% per year.
Upcoming Dividend • Jun 19Upcoming dividend of CN¥0.21 per share at 1.4% yieldEligible shareholders must have bought the stock before 26 June 2023. Payment date: 26 June 2023. Payout ratio is a comfortable 41% and the cash payout ratio is 91%. Trailing yield: 1.4%. Lower than top quartile of Chinese dividend payers (2.0%). Lower than average of industry peers (1.9%).
Reported Earnings • Apr 24Full year 2022 earnings: EPS and revenues miss analyst expectationsFull year 2022 results: EPS: CN¥0.67 (down from CN¥0.99 in FY 2021). Revenue: CN¥2.47b (flat on FY 2021). Net income: CN¥214.5m (down 31% from FY 2021). Profit margin: 8.7% (down from 13% in FY 2021). Revenue missed analyst estimates by 5.1%. Earnings per share (EPS) also missed analyst estimates by 15%. Revenue is forecast to grow 25% p.a. on average during the next 2 years, compared to a 17% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 7% per year but the company’s share price has fallen by 6% per year, which means it is significantly lagging earnings.
Valuation Update With 7 Day Price Move • Nov 04Investor sentiment improved over the past weekAfter last week's 16% share price gain to CN¥16.42, the stock trades at a trailing P/E ratio of 17.2x. Average trailing P/E is 27x in the Chemicals industry in China. Total returns to shareholders of 6.5% over the past three years.
Reported Earnings • Oct 28Third quarter 2022 earnings released: EPS: CN¥0.13 (vs CN¥0.20 in 3Q 2021)Third quarter 2022 results: EPS: CN¥0.13 (down from CN¥0.20 in 3Q 2021). Revenue: CN¥541.1m (down 7.6% from 3Q 2021). Net income: CN¥39.2m (down 39% from 3Q 2021). Profit margin: 7.2% (down from 11% in 3Q 2021). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings.
Valuation Update With 7 Day Price Move • Oct 18Investor sentiment improved over the past weekAfter last week's 17% share price gain to CN¥16.16, the stock trades at a trailing P/E ratio of 16.9x. Average trailing P/E is 26x in the Chemicals industry in China. Total returns to shareholders of 1.2% over the past three years.
Reported Earnings • Aug 26Second quarter 2022 earnings released: EPS: CN¥0.26 (vs CN¥0.26 in 2Q 2021)Second quarter 2022 results: EPS: CN¥0.26 (vs CN¥0.26 in 2Q 2021). Revenue: CN¥740.8m (up 16% from 2Q 2021). Net income: CN¥82.1m (flat on 2Q 2021). Profit margin: 11% (down from 13% in 2Q 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 15% per year but the company’s share price has only increased by 4% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Aug 01Investor sentiment improved over the past weekAfter last week's 18% share price gain to CN¥15.41, the stock trades at a trailing P/E ratio of 16.1x. Average trailing P/E is 29x in the Chemicals industry in China. Total returns to shareholders of 8.6% over the past three years.
Reported Earnings • Apr 29First quarter 2022 earnings released: EPS: CN¥0.21 (vs CN¥0.24 in 1Q 2021)First quarter 2022 results: EPS: CN¥0.21 (down from CN¥0.24 in 1Q 2021). Revenue: CN¥646.3m (up 8.4% from 1Q 2021). Net income: CN¥66.8m (down 11% from 1Q 2021). Profit margin: 10% (down from 13% in 1Q 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has fallen by 9% per year, which means it is significantly lagging earnings.
Reported Earnings • Nov 01Third quarter 2021 earnings released: EPS CN¥0.20 (vs CN¥0.23 in 3Q 2020)The company reported a soft third quarter result with weaker earnings and profit margins, although revenues improved. Third quarter 2021 results: Revenue: CN¥585.9m (up 14% from 3Q 2020). Net income: CN¥64.4m (down 13% from 3Q 2020). Profit margin: 11% (down from 14% in 3Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has only increased by 12% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Sep 29Investor sentiment deteriorated over the past weekAfter last week's 18% share price decline to CN¥15.44, the stock trades at a trailing P/E ratio of 15.6x. Average trailing P/E is 31x in the Chemicals industry in China. Total returns to shareholders of 49% over the past three years.
Reported Earnings • Aug 26Second quarter 2021 earnings released: EPS CN¥0.26 (vs CN¥0.23 in 2Q 2020)The company reported a solid second quarter result with improved earnings and revenues, although profit margins were weaker. Second quarter 2021 results: Revenue: CN¥641.3m (up 24% from 2Q 2020). Net income: CN¥82.4m (up 15% from 2Q 2020). Profit margin: 13% (down from 14% in 2Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 18% per year whereas the company’s share price has increased by 17% per year.
Reported Earnings • Apr 17Full year 2020 earnings released: EPS CN¥0.82 (vs CN¥0.72 in FY 2019)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: CN¥2.01b (up 1.2% from FY 2019). Net income: CN¥259.6m (up 14% from FY 2019). Profit margin: 13% (up from 12% in FY 2019). Over the last 3 years on average, earnings per share has increased by 17% per year whereas the company’s share price has increased by 16% per year.
Is New 90 Day High Low • Jan 27New 90-day low: CN¥13.86The company is down 5.0% from its price of CN¥14.62 on 29 October 2020. The Chinese market is up 9.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 21% over the same period.
Is New 90 Day High Low • Dec 16New 90-day low: CN¥13.90The company is down 10.0% from its price of CN¥15.52 on 17 September 2020. The Chinese market is up 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 6.0% over the same period.
Is New 90 Day High Low • Oct 30New 90-day low: CN¥14.15The company is down 19% from its price of CN¥17.37 on 31 July 2020. The Chinese market is down 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 2.0% over the same period.
Reported Earnings • Oct 28Third quarter earnings releasedOver the last 12 months the company has reported total profits of CN¥229.5m, up 7.6% from the prior year. Total revenue was CN¥1.91b over the last 12 months, down 1.5% from the prior year.
Is New 90 Day High Low • Sep 24New 90-day low: CN¥14.88The company is down 15% from its price of CN¥17.51 on 24 June 2020. The Chinese market is up 12% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 21% over the same period.